| CYHB2500799 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(4) | Supplementary Application | 2025-04-23 | | Hunan Kelun Pharmaceutical Co Ltd | | | view |
| CYHB2500800 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(4) | Supplementary Application | 2025-04-23 | | Hunan Kelun Pharmaceutical Co Ltd | | | view |
| JXHL2500083 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2025-04-16 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXHL2500082 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2025-04-16 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| CYHB2500293 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(4) | Supplementary Application | 2025-02-14 | | CSPC OUYI Pharmaceutical Co Ltd | | | view |
| CYHB2500292 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(4) | Supplementary Application | 2025-02-14 | | CSPC OUYI Pharmaceutical Co Ltd | | | view |
| CYHB2402054 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-12-04 | | Huadong Medicine (Xi'an) Bodyguard Pharmaceutical Co Ltd;Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | | | view |
| CYHB2402053 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-12-04 | | Huadong Medicine (Xi'an) Bodyguard Pharmaceutical Co Ltd;Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | | | view |
| JXHB2400174 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2024-11-08 | | AstraZeneca AB | | | view |
| JXHB2400173 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2024-11-08 | | AstraZeneca AB | | | view |
| JXHS2400080 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2024-10-11 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXHS2400081 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2024-10-11 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXHS2400004 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2024-01-09 | | Abbvie Ltd;AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXHS2400003 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2024-01-09 | | Abbvie Ltd;AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JYHB2300513 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2023-09-07 | | AstraZeneca AB | | | view |
| JYHB2300512 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2023-09-07 | | AstraZeneca AB | | | view |
| JYHS2300075 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-06-14 | | Natco Pharma Ltd | | | view |
| JYHS2300074 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-06-14 | | Natco Pharma Ltd | | | view |
| JXHB2300095 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2023-06-10 | | AstraZeneca AB | | | view |
| JXHB2300096 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2023-06-10 | | AstraZeneca AB | | | view |
